Associations between happiness with social factors and opioid agonist therapy among people who inject drugs

0
Associations between happiness with social factors and opioid agonist therapy among people who inject drugs
  • Veenhoven, R. Metrics of Subjective Well-Being: Limits and Improvements. (Springer International Publishing AG, ed.). (Springer, 2017). https://doi.org/10.1007/978-3-319-61810-4_4

  • Veenhoven, R. World Database of Happiness. Continuous Register of Research on Subjective Appreciation of Life. (2004). https://www.researchgate.net/publication/228659294_World_Database_of_Happiness_Continuous_register_of_research_on_subjective_appreciation_of_life

  • Helliwell, J. F. et al. World Happiness Report. (2003). https://happiness-report.s3.amazonaws.com/2023/WHR+23.pdf

  • Singh, S., Kshtriya, S., Valk, R. & Health hope, and harmony: A systematic review of the determinants of happiness across cultures and countries. Int. J. Environ. Res. Public Health 20(4), 3306. (2023).

  • Spinhoven, P., Elzinga, B. M., Penninx, B. W. J. H. & Giltay, E. J. Temporal relationships between happiness and psychiatric disorders and their symptom severity in a large cohort study: The Netherlands study of depression and anxiety (NESDA). BMC Psychiatry 21 (1). (2021).

  • Schuster, B. et al. Happiness and depression in psoriasis: a cross-sectional study in Germany. Qual. Life Res. 31 (6), 1761–1773. (2022).

    Article 
    PubMed 
    MATH 

    Google Scholar 

  • Mohaghegh, F., Moghaddasi, M., Eslami, M., Dadfar, M. & Lester, D. Disability and its association with psychological factors in multiple sclerosis patients. Mult Scler. Relat. Disord. 49, 102733. (2021).

    Article 
    PubMed 

    Google Scholar 

  • Bergsma, A., ten Have, M., Veenhoven, R. & de Graaf, R. Most people with mental disorders are happy: A 3-year follow-up in the Dutch general population. J. Posit. Psychol. 6 (4), 253–259. (2011).

    Article 

    Google Scholar 

  • Han, B., Compton, W. M., Blanco, C. & Colpe, L. J. Prevalence, treatment, and unmet treatment needs of US adults with mental health and substance use disorders. Health Aff Proj Hope. 36 (10), 1739–1747. (2017).

    Article 

    Google Scholar 

  • Bogdanowicz, K. M. et al. Double trouble: psychiatric comorbidity and opioid addiction-All-cause and cause-specific mortality. Drug Alcohol Depend. 148, 85–92. (2015).

    Article 
    PubMed 
    MATH 

    Google Scholar 

  • Aas, C. F. et al. Health-related quality of life of long-term patients receiving opioid agonist therapy: A nested prospective cohort study in Norway. Subst. Abus Treat. Prev. Policy. 15 (1). (2020). [Aprox. 12p.].

  • Andrews, G., Henderson, S. & Hall, W. Prevalence, comorbidity, disability and service utilisation overview of the Australian National mental health survey [published correction appears in Br J psychiatry 2001;179:561-2]. Br. J. Psychiatry. 178, 145–153. (2001).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Astals, M. et al. Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: An 18-month follow-up study. Int. J. Environ. Res. Public. Health 6(11), 2822–2832. (2009 Nov).

  • Aas, C. F. et al. Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Subst. Abus Treat. Prev. Policy. 16 (1). (2021) (aprox. 10p.).

  • Degenhardt, L. et al. Global patterns of opioid use and dependence: population harms, interventions, and future action Louisa. Lancet 394 (10208), 1560–1579. (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 
    MATH 

    Google Scholar 

  • Karow, A. et al. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence. Drug Alcohol Depend. 112 (3), 209–215. (2010).

    Article 
    CAS 
    PubMed 
    MATH 

    Google Scholar 

  • Bahji, A., Cheng, B., Gray, S. & Stuart, H. Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis. Acta Psychiatr Scand. 140 (4), 313–339. (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Moazen-Zadeh, E. et al. Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials. Am. J. Drug Alcohol Abuse. 47 (3), 280–304. (2021).

    Article 
    PubMed 

    Google Scholar 

  • Schober, P. & Vetter, T. R. Survival analysis and interpretation of Time-to-Event data: the tortoise and the hare. Anesth. Analg. 127 (3), 792–798. (2018).

    Article 
    PubMed 
    PubMed Central 
    MATH 

    Google Scholar 

  • Ghys, P. D., Williams, B. G., Over, M., Hallett, T. B. & Godfrey-Faussett, P. Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS Med. 15 (10), e1002678. (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Castaldelli-Maia, J. M. & Bhugra, D. Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels. Int. Rev. Psychiatry. 34 (1), 6–15. (2022).

    Article 
    PubMed 

    Google Scholar 

  • National Institute on Drug Abuse [NIDA]. Common Comorbidities with Substance Use Disorders Research Report Part 2: Co-Occurring Substance Use Disorder and Physical Comorbidities. (2020). https://nida.nih.gov/publications/research-reports/common-comorbidities-substance-use-disorders/part-2-co-occurring-substance-use-disorder-physical-comorbidities

  • Frølich, A., Ghith, N., Schiøtz, M., Jacobsen, R. & Stockmarr, A. Multimorbidity, healthcare utilization and socioeconomic status: A register-based study in Denmark. PLoS One. 14 (8), e0214183. (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 
    MATH 

    Google Scholar 

  • Simirea, M. et al. Health-related quality of life in outpatients with substance use disorder: evolution over time and associated factors. Health Qual. Life Outcomes. 20 (1), 26. (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and National incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392 (10159), 1789–1858. (2018).

    Article 

    Google Scholar 

  • Foulis, S. J. et al. Patient-centered addiction medicine: what patients say helps them the most in their recovery – the role of whole-person healthcare and prayer in opioid addiction recovery. Curr. Psychol. (2022).

    Article 

    Google Scholar 

  • Bentzley, B. S., Barth, K. S., Back, S. E. & Book, S. W. Discontinuation of buprenorphine maintenance therapy: Perspectives and outcomes. J. Subst. Abuse Treat. 52, 48–57. (2015).

  • Nelson, E. E. & Essien, N. F. Redefining recovery: accounts of treatment experiences of dependent cannabis users in Nigeria. J. Subst. Abuse Treat. 125, 108321. (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Rhodes, T., Ndimbii, J., Guise, A., Cullen, L. & Ayon, S. Navigating the poverty of heroin addiction treatment and recovery opportunity in Kenya: access work, self-care and rationed expectations. Glob Public. Health. 10 (7), 867–880. (2015).

    Article 
    PubMed 

    Google Scholar 

  • Fadnes, L. T. et al. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). BMC Infect. Dis. 18 (6), 1–9. (2019).

    Article 
    MATH 

    Google Scholar 

  • Fadnes, L. T. et al. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS Med. 18 (6), e1003653. (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • World Health Organization (WHO). International Classification of Diseases (ICD). Accessed May 10. (2023). https://www.who.int/classifications/classification-of-diseases

  • Schmalbach, B. et al. Psychometric properties of two brief versions of the Hopkins symptom checklist: HSCL-5 and HSCL-10. Assessment 28 (2), 617–631. (2019).

    Article 
    PubMed 

    Google Scholar 

  • Strand, B. H., Dalgard, O. S., Tambs, K. & Rognerud, M. Measuring the mental health status of the Norwegian population: A comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J. Psychiatry. 57 (2), 113–118. (2003).

    Article 
    PubMed 

    Google Scholar 

  • Kleppang, A. L. & Hagquist, C. The psychometric properties of the Hopkins symptom Checklist-10: a Rasch analysis based on adolescent data from Norway. Fam. Pract. 33 (6), 740–745. (2016).

    Article 
    PubMed 

    Google Scholar 

  • Wangensteen, T. & Hystad, J. Trust and collaboration between patients and staff in SUD treatment: A qualitative study of patients’ reflections on inpatient SUD treatment four years after discharge. Nordisk Alkohol Nark. 39 (4), 418–436. (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Gonzales, R., Anglin, M. D., Beattie, R., Ong, C. A. & Glik, D. C. Perceptions of chronicity and recovery among youth in treatment for substance use problems. J. Adolesc. Health. 51 (2), 144–149. (2012).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Martinelli, T. F. et al. Comparing three stages of addiction recovery: long-term recovery and its relation to housing problems, crime, occupation situation, and substance use. Drugs Educ. Prev. Policy. 27 (5), 387–396. (2020).

    Article 
    MATH 

    Google Scholar 

  • Feliu-Soler, A. et al. Unhappy while depressed: examining the dimensionality, reliability and validity of the subjective happiness scale in a Spanish sample of patients with depressive disorders. Int. J. Environ. Res. Public. Health. 18 (20), 1–13. (2021).

    Article 
    MATH 

    Google Scholar 

  • Gutiérrez-Rojas, L., González-Domenech, P. J., Junquera, G., Halverson, T. F. & Lahera, G. Functioning and happiness in people with schizophrenia: analyzing the role of cognitive impairment. Int. J. Environ. Res. Public. Health. 18 (14), 1–14. (2021).

    Article 

    Google Scholar 

  • Erga, A. H. et al. Trajectories of psychological distress during recovery from polysubstance use disorder. Addict. Res. Theory. 29 (1), 64–71. (2021).

    Article 

    Google Scholar 

  • Díaz Hernández, E. L., Brito Brito, P. R. & García Hernández, A. M. Happiness and mental disorders. Healthcare 10 (9). (2022).

  • Garaigordobil, M. Predictor variables of happiness and its connection with risk and protective factors for health. Front. Psychol. 6, 1–10. (2015).

    Article 

    Google Scholar 

  • Crego, A., Yela, J. R., Gómez-Martínez, M. Á., Riesco-Matías, P. & Petisco-Rodríguez, C. Relationships between mindfulness, purpose in life, happiness, anxiety, and depression: testing a mediation model in a sample of women. Int. J. Environ. Res. Public. Health. 18 (3), 925. (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Schick, M. R., Spillane, N. S., Breines, J. G. & Kahler, C. W. Positive psychological characteristics and substance use in first Nation adolescents. Subst. Use Misuse. 57 (8), 1196–1206. (2022).

    Article 
    PubMed 
    MATH 

    Google Scholar 

  • Buijs, V. L. et al. Social needs and happiness: A life course perspective. J Happiness Stud. 22, 1953 (1978). (2021).

  • Vold, J. H. et al. Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway. BMC Psychiatry. 22 (1), 181. (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 
    MATH 

    Google Scholar 

  • Hoxmark, E., Benum, V., Friborg, O. & Wynn, R. Reduction in mental distress among substance users receiving inpatient treatment. Int. J. Ment Health Syst. 4 (30). (2010).

  • Gossop, M., Marsden, J. & Stewart, D. Remission of psychiatric symptoms among drug misusers after drug dependence treatment. J. Nerv. Ment Dis. 194 (11), 826–832. (2006).

    Article 
    PubMed 

    Google Scholar 

  • Nunes, E. V., Sullivan, M. A. & Levin, F. R. Treatment of depression in patients with opiate dependence. Biol. Psychiatry. 56 (10), 793–802. (2004).

    Article 
    CAS 
    PubMed 
    MATH 

    Google Scholar 

  • Roozen, H. G., Greeven, P. J. G. & Dijkstra, B. B. G. Verbesserung Bei patienten durch Den community reinforcement approach: effekte auf zufriedenheit und psychiatrische symptome. Suchttherapie 14 (2), 1–6. (2013).

    Article 

    Google Scholar 

  • link

    Leave a Reply

    Your email address will not be published. Required fields are marked *